TrialThe New England journal of medicine2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Mark R Litzow et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
161 papers cite itlatest 60 shown
this paperpooled ittrialcites it